MMR Vaccine might give protection against severe Covid-19 bouts

A study published in the journal mBIO says that the measles-mumps-rubella (MMR) vaccine may be the reason why children are less susceptible to the Covid-19 virus, and it may open up another avenue of protection against the virus.

The study found that mumps IgG titers, or levels of IgG antibody, are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with the MMR II vaccine.

MMR II contains the Edmonston strain of measles, the Jeryl Lynn (B-level) strain of mumps, and the Wistar RA 27/3 strain of rubella, the researchers said.

“We found a statistically significant inverse correlation between mumps titer levels and COVID-19 severity in people under age 42 who have had MMR II vaccinations,” said lead study author Jeffrey E. Gold, president of World Organization in Georgia, US.

“This adds to other associations demonstrating that the MMR vaccine may be protective against COVID-19. It also may explain why children have a much lower COVID-19 case rate than adults, as well as a much lower death rate,” said Gold. “ The majority of children get their first MMR vaccination around 12 to 15 months of age and a second one from 4 to 6 years of age,” he added.

COVID MMR Vaccine

The researchers divided the 80 subjects into 2 groups for the purpose of the study. One group consisted of 50 US subjects who already had antibodies from the MMR II vaccine.

The other group consisted of 30 people who had not been given the MMR II vaccinations, and would primarily have MMR antibodies from other sources, including prior measles, mumps, and/or rubella illnesses.

The researchers found a significant inverse correlation between mumps titers and COVID-19 severity within the MMR II group.

No such correlation between the mumps titers and severity of the disease was found in the comparison group, between mumps titers and age in the MMR II group, or between severity and measles or rubella titers in either group.

Within the MMR II group, mumps titers of 134 to 300 AU/ml were only found in those who were functionally immune or asymptomatic. All with mild COVID-19 symptoms had mumps titers below 134 AU/ml. All with moderate symptoms had mumps titers below 75 AU/ml. All who had been hospitalized and required oxygen had mumps titers below 32 AU/ml.

“This is the first immunological study to evaluate the relationship between the MMR II vaccine and COVID-19. The statistically significant inverse correlation between mumps titers and COVID-19 indicates that there is a relationship involved that warrants further investigation,” said study co-author David J. Hurley professor and molecular microbiologist at the University of Georgia.

“The MMR II vaccine is considered a safe vaccine with very few side effects. If it has the ultimate benefit of preventing infection from COVID-19, preventing the spread of COVID-19, reducing the severity of it, or a combination of any or all of those, it is a very high reward low risk ratio intervention,” Hurley said.

“Maximum seropositivity is achieved through two vaccinations at least 28 days apart. Based upon our study, it would be prudent to vaccinate those over 40 regardless of whether or not they already have high serum MMR titers,” he added.

Avatar
Christy Gren
Christy Gren is an Industry Specialist Reporter at Industry Leaders Magazine; she enjoys writing about Unicorns, Silicon Valley, Startups, Business Leaders and Innovators. Her articles provide an insight about the Power Players in the field of Technology, Auto, Manufacturing, and F&B.

Recent Posts

Moderna forecasts $18.4 billion revenue for 2021

Moderna forecasts $18.4 billion revenue for 2021

Moderna Inc., the Boston-based biotech startup, reported its fourth quarter and 2020 fiscal year results, where it announced that it hoped t...
11 hours ago
Hyundai Motor recalls 81,000 EVs for battery defect, may prove to be the costliest recall

Hyundai Motor recalls 81,000 EVs for battery defect, may prove to be the costliest recall

Hyundai Motor says the vehicle recalls are expected to cost the company about 1 trillion won or an estimated $900 million. In South Korea, 2...
11 hours ago
Accor reports $2.5 billion loss, hopeful of a recovery by next year

Accor reports $2.5 billion loss, hopeful of a recovery by next year

Accor, Europe’s largest hotel chain, reported a $2.5 billion net loss in 2020 due to the deterioration in the industry linked to the sprea...
1 day ago
Is the sun shining again on AMC stock?

Is the sun shining again on AMC stock?

As the old adage goes, good things come to those who wait. This might come true for movie theatre operator AMC Entertainment Holdings Inc. w...
1 day ago
HSBC turns to Asia for future growth

HSBC turns to Asia for future growth

The bank’s maximum pre-tax benefits (90%) come from its Asian business. Chairman Mark Tucker and chief executive Noel Quinn are strugg...
2 days ago
Wells Fargo to forego asset management unit to private equity for $2.1 billion

Wells Fargo to forego asset management unit to private equity for $2.1 billion

Wells Fargo has been underperforming for the past few years and has undertaken cost-cutting and restructuring to improve its numbers. Wells ...
2 days ago